Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
, 13, 1-4

Curative Two-Stage Resection for Synchronous Triple Cancers of the Esophagus, Colon, and Liver: Report of a Case


Curative Two-Stage Resection for Synchronous Triple Cancers of the Esophagus, Colon, and Liver: Report of a Case

Yuji Akiyama et al. Int J Surg Case Rep.


Introduction: Cases of synchronous triple cancers of the esophagus and other organs curatively resected are rare.

Presentation of case: A 73-year-old man was admitted to our hospital with bloody feces. He was diagnosed with synchronous triple cancers of the esophagus, colon, and liver. We selected a two-stage operation to safely achieve curative resection for all three cancers. The first stage of the operation comprised a laparoscopy-assisted sigmoidectomy and partial liver resection via open surgery. The patient was discharged without complications. Thirty days later, he was readmitted and thoracoscopic esophagectomy was performed. Although pneumonia-induced pulmonary aspiration occurred as a postoperative complication, it was treated conservatively. The patient was discharged on postoperative day 24.

Discussion: Esophagectomy is a highly invasive procedure; thus, simultaneous surgery for plural organs, including the esophagus, may induce life-threatening, severe complications. Two-stage surgery is useful in reducing surgical stress in high-risk patients. For synchronous multiple cancers, the planning of two-stage surgery should be considered for each cancer to maintain organ function and reduce the stress and difficulty of each stage.

Conclusion: We successfully treated synchronous triple cancers, including esophageal cancer, by a two-stage operation.

Keywords: Esophageal cancer; Synchronous triple cancers; Two-stage operation.


Fig. 1
Fig. 1
(a) Barium enema showed two tumors as defects in the sigmoid colon (arrows). (b) Surgical specimen of the sigmoid colon (arrows). (c) Pathological specimen from the sigmoid colon showed a moderately differentiated adenocarcinoma.
Fig. 2
Fig. 2
(a) Esophagogastroscopy revealed a superficial elevated lesion with a surrounding Lugol-voiding lesion from 27 cm to 30 cm below the incisor. (b) Surgical specimen of the esophagus. (c) Pathological examination of a specimen from the esophagus showed poorly differentiated squamous cell carcinoma.
Fig. 3
Fig. 3
(a) A CT scan during hepatic arteriography showed a 7 cm, high-density area on S4 and S8. (b) Surgical specimen of the liver. (c) Pathological examination of a specimen from the liver showed moderately differentiated HCC.

Similar articles

See all similar articles

Cited by 2 PubMed Central articles


    1. Natsugoe S., Matsumoto M., Okamura H., Ishigami S., Uenosono Y., Owaki T., Takeo S., Aikou T. Multiple primary carcinomas with esophageal squamous cell cancer: clinicopathologic outcome. World J. Surg. 2005;29:46–49. - PubMed
    1. Miyazaki T., Sohda M., Higuchi T., Tanaka N., Suzuki S., Sakai M., Yokobori T., Nakajima M., Fukuchi M., Tsushima Y., Kato H., Kuwano H. Effectiveness of FDG-PET in screening of synchronous cancer of other organs in patients with esophageal cancer. Anticancer Res. 2014;34:283–287. - PubMed
    1. Kumagai Y., Kuwano T., Nakajima Y., Nagai K., Inoue H., Nara S., Iwai T. Multiple primary cancers associated with esophageal carcinoma. Surg. Today. 2001;31:872–876. - PubMed
    1. Koide N., Yazawa K., Koike S., Adachi W., Amano J. Oesophageal cancer associated with other primary cancers: a study of 31 patients. J. Gastroenterol. Hepatol. 1997;12:690–694. - PubMed
    1. Poon R.T., Law S.Y., Chu K.M., Branicki F.J., Wong J. Multiple primary cancers in esophageal squamous cell carcinoma: incidence and implications. Ann. Thorac. Surg. 1998;65:1529–1534. - PubMed